ChemicalBook > CAS DataBase List > Sodium Stibogluconate

Sodium Stibogluconate

Product Name
Sodium Stibogluconate
CAS No.
16037-91-5
Chemical Name
Sodium Stibogluconate
Synonyms
SSG;NASB;NASBV;solustin;stibatin;stibinol;pentostam;myostibin;stibanate;stibanose
CBNumber
CB0328463
Molecular Formula
C12H37Na3O27Sb2
Formula Weight
925.9
MOL File
16037-91-5.mol
More
Less

Sodium Stibogluconate Property

Melting point:
>250°C (dec,)
storage temp. 
2-8°C
solubility 
H2O: 1 mg/mL at ~75 °C
form 
solid
color 
pale yellow
Stability:
Hygroscopic
InChIKey
VJCZMGLJTJZFEN-ZYPIZMQFSA-K
CAS DataBase Reference
16037-91-5
More
Less

Safety

Hazard Codes 
Xn,N
Risk Statements 
20/22-51/53
Safety Statements 
61
RIDADR 
3282
WGK Germany 
3
RTECS 
CC7930000
HazardClass 
6.1(b)
PackingGroup 
III
Toxicity
LD50 ipr-mus: 33 mg/kg CLDND* 11,155,49
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H411Toxic to aquatic life with long lasting effects

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P273Avoid release to the environment.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
567565
Product name
Sodium Stibogluconate - CAS 16037-91-5 - Calbiochem
Packaging
1g
Price
$144
Updated
2024/03/01
Cayman Chemical
Product number
16038
Product name
Sodium Stibogluconate
Purity
≥95%
Packaging
250mg
Price
$49
Updated
2024/03/01
Cayman Chemical
Product number
16038
Product name
Sodium Stibogluconate
Purity
≥95%
Packaging
1g
Price
$153
Updated
2024/03/01
Cayman Chemical
Product number
16038
Product name
Sodium Stibogluconate
Purity
≥95%
Packaging
500mg
Price
$87
Updated
2024/03/01
TRC
Product number
S670960
Product name
Sodium Stibogluconate
Packaging
5g
Price
$325
Updated
2021/12/16
More
Less

Sodium Stibogluconate Chemical Properties,Usage,Production

Description

Sodium stibogluconate is a pentavalent antimony derivative that is highly active against Leishmania amastigotes in macrophages. Sodium stibogluconate has diverse effects on both this intracellular parasite and its host cell.

Uses

Sodium Stibogluconate is an intermediate used to prepare Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.

Uses

Sodium stibogluconate is a pentavalent antimony derivative that is highly active against Leishmania amastigotes in macrophages. Sodium stibogluconate has diverse effects on both this intracellular parasite and its host cell.

Antimicrobial activity

It has low activity against the extracellular promastigote stage of Leishmania spp. in vitro, but is active against amastigotes in macrophages. The trivalent form is considered to be the toxophore, with metabolism of SbV to toxic SbIII in the host cell macrophage and the parasite; the level of metabolism is higher in amastigotes than promastigotes. Variation in the sensitivity of different Leishmania species may contribute to differences in clinical response. It is more active against visceral than cutaneous leishmaniasis in animal models. Sodium stibogluconate cures CNS infections with T. brucei in rodents.

Acquired resistance

Unresponsiveness and relapse of L. donovani infections in Bihar State, India (over 60% of cases), is due to increasing acquired resistance. In laboratory-generated and clinical isolates, resistant Leishmania promastigotes show increased levels of intracellular thiols, for example trypanothione, to which SbIII is conjugated and extruded by efflux pumps.
Lack of response is also reported in patients with mucosal leishmaniasis caused by L. braziliensis. Relapse is common in patients with visceral leishmaniasis who are immunosuppressed, for example by HIV infection, but this is due to pathogen interaction and the immune dependence of drug activity and not acquired resistance. High mortality has been reported in treatment of these co-infection cases.

Pharmaceutical Applications

A pentavalent antimonial of uncertain chemical composition; probably a complex mixture of polymeric forms. There is batchto- batch variation and solutions may contain 32–34% pentavalent antimony (SbV). The structural formula is conjectural as studies have identified a mixture of non-complexed SbV and large polymeric gluconate complexes. Chemical composition also depends on concentration and time. It is freely soluble in water.

Pharmacokinetics

Peak concentrations of about 12–15 mg antimony/L are achieved in serum 1 h after a dose of 10 mg/kg. There is a slow accumulation in the central compartment, and tissue concentrations reach a maximum after several days. In contrast to trivalent derivatives, pentavalent antimonials are not accumulated by erythrocytes, but there is evidence of protein binding. Antimony is detected in the skin for at least 5 days after treatment. Some of the dose of SbV is converted to SbIII, possibly by the liver or by macrophages. It is rapidly excreted into urine with a half-life of about 2 h; 60–80% of the dose appears in the urine within 6 h of parenteral administration. In a study on structurally related meglumine antimonate the pharmacokinetics of SbV and SbIII were similar as measured by serum and urine levels.

Clinical Use

Sodium antimony gluconate (Pentostam) is a pentavalent antimonialcompound intended primarily for the treatment ofvarious forms of leishmaniasis. It is available from the CDCas the disodium salt, which is chemically stable and freelysoluble in water. The 10% aqueous solution used for eitherintramuscular or intravenous injection has a pH of approximately5.5. Like all antimonial drugs, this drug has a lowtherapeutic index, and patients undergoing therapy with itshould be monitored carefully for signs of heavy metal poisoning.Other organic antimonial compounds are used primarilyfor the treatment of schistosomiasis and other flukes.The antileishmanial action of sodium stibogluconate requiresits reduction to the trivalent form, which is believedto inhibit phosphofructokinase in the parasite.

Clinical Use

Visceral, cutaneous and mucocutaneous leishmaniasis
The combination with paromomycin has been used in unresponsive cases and in relapses of visceral and cutaneous leishmaniasis.

Side effects

The toxic effects are limited by the rapid excretion, but cumulative toxicity increases in proportion to dose. Myalgia, arthralgia, anorexia and electrocardiographic changes have been reported with high-dose regimens. In particular, development of ventricular tachyarrhythmias associated with prolongation of the QT interval has been recorded. Hepatocellular damage, hepatic and renal functional impairment and pancreatitis have also been reported. The changes are reversible on discontinuation of treatment.

Safety Profile

Poison by intraperitoneal route. When heated to decomposition it emits toxic fumes of Sb.

Veterinary Drugs and Treatments

Sodium stibogluconate is used for the treatment of leishmaniasis in dogs.

Drug interactions

otentially hazardous interactions with other drugs
P Antifungals: possible increased risk of arrhythmias with amphotericin - give 14 days apart.

Metabolism

No data on possible metabolic pathways.
Elimination occurs in two phases; a rapid initial phase, in which the majority of a dose is excreted via the kidneys within 12 hours, and a slower phase, possibly reflecting reduction to trivalent antimony.

Sodium Stibogluconate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Sodium Stibogluconate Suppliers

Wuhan FengyaoTonghui Chemical Products Co., Ltd.
Tel
027-87466105 15377573527
Email
2678564200@qq.com
Country
China
ProdList
17997
Advantage
58
China Langchem Inc.
Tel
0086-21-58956006
Fax
0086-21-58956100
Country
China
ProdList
7815
Advantage
57
Hunan Hui Bai Shi Biotechnology Co., Ltd.
Tel
0731-85526065 13308475853
Email
ivy@hnhbsj.com
Country
China
ProdList
4548
Advantage
62
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
27322
Advantage
60
Shandong Xiya Chemical Co., Ltd.
Tel
4009903999 13395398332
Fax
0539-6365991
Email
sales@xiyashiji.com
Country
China
ProdList
20810
Advantage
60
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 4009686088
Email
3193328036@qq.com
Country
China
ProdList
29797
Advantage
68
Wellman Pharmaceutical Group Limited
Tel
027-027-83778875 15807197853
Fax
027-83991220
Email
15807197853@163.com
Country
China
ProdList
3978
Advantage
58
Amatek Scientific Co. Ltd.
Tel
0512-56316828
Fax
0512-56316826
Email
info@amateksci.com
Country
China
ProdList
28822
Advantage
58
Shandong Ono Chemical Co., Ltd.
Tel
0539-6362799 20)
Fax
0539-6362799(To 20)
Country
China
ProdList
9998
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4662
Advantage
60
More
Less

View Lastest Price from Sodium Stibogluconate manufacturers

shandong perfect biotechnology co.ltd
Product
Sodium Stibogluconate 16037-91-5
Price
US $0.00/KG
Min. Order
1KG
Purity
98% HPLC
Supply Ability
5000kgs
Release date
2023-07-07
Dideu Industries Group Limited
Product
Sodium Stibogluconate 16037-91-5
Price
US $1.10/g
Min. Order
1g
Purity
99.9%
Supply Ability
100 Tons Min
Release date
2021-06-18
Shaanxi Dideu Medichem Co. Ltd
Product
Sodium Stibogluconate 16037-91-5
Price
US $0.00-0.00/Kg
Min. Order
1KG
Purity
99.0%
Supply Ability
500 tons
Release date
2020-04-27

16037-91-5, Sodium StibogluconateRelated Search:


  • SODIUM STIBOGLUCONATE
  • SSG
  • NASB
  • NASBV
  • d-gluconicacid,2,4:2’,4’-o-(oxydistibylidyne)bis-,sb,sb’-dioxide,trisodium
  • d-gluconicacid,cyclicesterwithantimonicacid(h8sb2o9)(2:1),trisodium
  • estibogluconatosodico
  • myostibin
  • pentostam
  • salt,nonahydrate
  • solustibosan
  • solustin
  • solusurmin
  • solyusurmin
  • stibanate
  • stibanose
  • stibatin
  • stibinol
  • Sodium Stibogluconate - CAS 16037-91-5 - Calbiochem
  • ANTIMONY SODIUM GLUCONATE
  • Antimony(V) sodium gluconate
  • Sodium stibagluconate
  • Aids007935
  • Aids-007935
  • Stibogluconate (sodium)
  • Stibogluconate trisodium nonahydrate
  • Sodium Stibogluconate USP/EP/BP
  • D-Gluconic acid,2,4:2',4'-O-(oxydistibylidyne)bis-, sodium salt, hydrate (1:3:9)
  • Phosphatase,inhibit,Sodium stibogluconate,Inhibitor
  • 16037-91-5
  • C12H18Na3O17Sb2
  • C12H37Na3O27Sb2
  • C12H18Na2O17Sb2
  • C12H17O17Sb23Na
  • C12H17O17Sb29H2O3Na
  • Cell Signaling and Neuroscience
  • Cell Biology
  • BioChemical
  • Kinase/Phosphatase Biology
  • Tyrosine Phosphatase (TP)
  • Tyrosine Phosphatase Inhibitors